Skip to content
Other

Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1

West Pharmaceutical Services Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 increased by 11.1% to $3M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 25.0%, from $2.4M to $3M.

Analysis

StatementIncome Statement
SectionOther
First reportedQ1 2015
Last reportedQ1 2026Apr 23, 2026
Metric ID: other_business_combination_contingent_consideration_arra_61a2d2

Historical Data

15 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$200K$100K$800K$300K$1.5M$300K$500K$700K$1M$1M$1.2M$2.4M$2.2M$2.7M$3M
QoQ Change-50.0%+700.0%-62.5%+400.0%-80.0%+66.7%+40.0%+42.9%+0.0%+20.0%+100.0%-8.3%+22.7%+11.1%
YoY Change+50.0%>999%-62.5%+66.7%-53.3%+233.3%+100.0%+71.4%+140.0%+120.0%+125.0%+25.0%
Range$100K$3M
CAGR+116.8%
Avg YoY Growth+184.6%
Median YoY Growth+85.7%
Current Streak2 quarters growth

Frequently Asked Questions

What is West Pharmaceutical Services's business combination contingent consideration arrangements change in amount of contingent consideration liability1?
West Pharmaceutical Services (WST) reported business combination contingent consideration arrangements change in amount of contingent consideration liability1 of $3M in Q1 2026.
How has West Pharmaceutical Services's business combination contingent consideration arrangements change in amount of contingent consideration liability1 changed year-over-year?
West Pharmaceutical Services's business combination contingent consideration arrangements change in amount of contingent consideration liability1 increased by 25.0% year-over-year, from $2.4M to $3M.